Erytech Pharma S.A. (ERYP)


Erytech Pharma S.A. (ERYP)

$6.93 USD

0.29 (4.37%)

Updated Jun 11 6:55pm

Add ERYP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 207 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

ERYP Daily Price Range
ERYP 52-Week Price Range

ERYP News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All ERYP News

Erytech Pharma S.A. (ERYP) Company Bio


ERYTECH Pharma Société Anonyme, a clinical-stage biopharmaceutical company, develops therapies for rare forms of cancer and orphan diseases in France and internationally. The company is developing a pipeline of product candidates targeting markets with unmet medical need using its proprietary ERYCAPS platform, a technology to encapsulate therapeutic drug substances inside red blood cells. It primarily focuses on the treatment of blood cancers, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), by depriving tumors of nutrients necessary for their survival. The company was founded in 2004 and is based in Lyon, France.

ERYP Stock Chart More Charts


ERYP Price/Volume Stats

Current price $6.93
Prev. close $6.64
Day low $6.93
Day high $7.38
50-day MA $7.64
200-day MA $8.87
52-week high $18.45
52-week low $5.45
Volume 3,000
Avg. volume 2,568
Dividend yield N/A
Market Cap 124.32M

ERYP Social Stream


Loading social stream, please wait...

View Full ERYP Social Stream

ERYP Returns

1-mo -3.50%
3-mo -19.42%
6-mo 12.50%
1-year -61.65%
3-year N/A
5-year N/A
YTD 2.36%
2018 -69.26%
2017 N/A
2016 N/A
2015 N/A
2014 N/A
Page generated in 0.4028 seconds.